logo
Agentic AI: Driving Autonomy In Asset-Intensive Industries

Agentic AI: Driving Autonomy In Asset-Intensive Industries

Forbes2 days ago
Vivek Ahuja, VP-IT at rSTAR , spearheading business and IT transformation with a focus on manufacturing, energy/utilities and construction. getty
I've previously discussed the new frontier in AI: agentic AI. It's the next evolution in the AI timeline. However, is it hype, or will it be a game changer—especially for asset-intensive industries? If agentic AI is a game changer, how can companies get started using it?
Agentic AI continues the progression of AI. What began as rudimentary chatbots programmed to respond to queries based on keywords eventually evolved into GenAI. Using large language models and machine learning, GenAI platforms moved beyond the responses of chatbots to evolve and grow ("learn") from their interactions with people.
Agentic AI takes GenAI another step further by adding an autonomous dimension to the agentic agent. Depending on how the agentic AI agent is programmed, it can act autonomously within specific parameters or guardrails. In other words, it can take action on its own. For example, it can interact with multiple systems, such as email and instant messaging platforms, and send customers messages based on a predetermined schedule.
When integrated into your company's enterprise resource planning (ERP), customer relationship management (CRM) and other systems, agentic AI can assist with workflows, communications and tasks. Agentic AI Use Cases For Asset-Intensive Industries
Asset-intensive industries often have many complex workflows. A utility, for example, has many workflows related to field service, asset management, outage resolution and so on. In manufacturing, complex workflows include case management, support services, efficiency and compliance.
In a utility environment, outage resolution is one of the more complex workflows. It touches everything from SCADA systems and customer complaints to field dispatch, asset lookup and compliance. Today, much of this is still manual, disconnected and dependent on individual know-how.
Agentic AI acts like an intelligent coordinator, detecting issues early, planning and dispatching the right crews based on real-time availability, pulling up asset history from different systems and even guiding field techs through mobile assistants. It also keeps customers updated automatically and ensures compliance checks are in place. The real value is in how it brings everything together, reduces response time and creates a smoother, more efficient experience for the utility and the customer.
Before you rush to add agentic AI to your technology stack, consider your company's overall technical maturity. The launch of successful agents depends heavily on system integration. Agentic AI can provide insights, but it cannot take meaningful workflow actions until it integrates with core systems.
As with all AI projects, ensuring the system has plentiful, clean data is necessary. Governance and standards must be in place to ensure boundaries around AI use. Steps To Get Started
If you are interested in exploring agentic AI, here are some best practices to get started.
1. Choose a small pilot project to get started. Focus on projects with clear, tangible metrics and ROI to assess the benefits.
2. Focus on a narrow use case to reduce the risk of scope creep. It helps focus the project on specific, measurable uses.
3. Ensure systems are integrated before adopting agentic AI.
4. Follow a replicable pattern for the project, beginning with a clear, written proof of concept, a pilot project and then the production of the agentic AI. Include measurable results to assess project success.
5. Build governance into the project. Don't tack it on as an afterthought. Too many companies build AI models and try to apply governance later, which runs the risk of project delays and problems. Agentic AI: Your Personal Assistant
Agentic AI won't replace workers. Instead, it extends their abilities through autonomous, guided actions. It offers efficiency in many industries but can be especially advantageous for asset-intensive industries such as energy and utilities and manufacturing.
To achieve AI project goals, companies must ensure they have the right building blocks in place: clean data, an identifiable and narrow use case, system integration and governance built into the project from its inception. With the right items in place, agentic AI can be a powerful force for change.
Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

3 AI-Driven Medical Device Stocks to Watch in 2025
3 AI-Driven Medical Device Stocks to Watch in 2025

Yahoo

time3 hours ago

  • Yahoo

3 AI-Driven Medical Device Stocks to Watch in 2025

Globally, generative artificial intelligence (Gen AI) and agentic AI are increasingly being integrated into medical devices, transforming both clinical workflows and patient care. Gen AI is primarily being used for content creation and design optimization within the medical device space. For instance, Gen AI models generate synthetic medical images like magnetic resonance imaging (MRI), computed tomography (CT) and X-rays to train diagnostic tools and augment datasets. NVIDIA NVDA cofounded the Medical Open Network for AI ('MONAI') with the world's leading academic medical centers to establish an inclusive community of AI researchers, developing and exchanging best practices for AI in healthcare imaging across academia and enterprise researchers. Additionally, Gen AI powers real-time clinical documentation tools embedded within diagnostic devices, such as Nuance Communications's Dragon Ambient eXperience ('DAX'). These devices transcribe doctor-patient conversations into structured clinical notes, minimizing administrative burden and enhancing documentation accuracy. Alternatively, agentic AI enables medical devices to act autonomously and make decisions based on real-time data. Agentic AI also supports predictive maintenance in connected medical equipment, such as MRIs and ventilators. This enables fault detection and automated service scheduling, thereby reducing equipment downtime. In the surgical field, AI-guided robotic systems, such as Intuitive Surgical's ISRG da Vinci platform, are integrating agentic AI features to assist with real-time tissue navigation and instrument movement. Here, we have picked three medical devices stocks, namely Boston Scientific Corporation BSX, Johnson & Johnson JNJ and GE HealthCare Technologies Inc. GEHC, which are likely to perform well in 2025, driven by strong AI adoption. Rising Demand for Precision and Personalized Medicine: AI enables medical devices to deliver highly individualized diagnostics and treatments. For instance, AI algorithms can analyze patient-specific imaging data or genetic profiles to guide the design of implants, surgical plans, or therapeutic regimens, improving patient outcomes. Favorable Regulatory Environment: Regulatory oversight for AI in the United States falls under the FDA's Software as a Medical Device (SaMD) segment. Over 700 AI-enabled devices have been approved, which is more than 10 times the number available in 2020. In January, the FDA released a draft guidance on adaptive AI systems, which have reduced uncertainty for developers, encouraging innovation and faster approvals. Boston Scientific is a major manufacturer of interventional medical devices. The company has been investing in AI to support its devices and improve procedural outcomes. It's HeartLogic is a heart failure diagnostic that utilizes AI to detect worsening heart failure in patients with implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds). The Rhythm AI module in the Rhythmia HDx mapping system can automatically interpret electroanatomical maps to identify arrhythmia circuits, enabling electrophysiologists to target ablation therapy more effectively. Meanwhile, the company's Coronary Advanced Analysis software uses AI to analyze optical coherence tomography images to characterize plaque. Boston Scientific, carrying a Zacks Rank #2 (Buy) at present, has a projected 2025 sales growth rate of 16.4%, higher than the industry's flat growth. The company has a favorable current cashflow rate of 26.5% against the industry's -2.6%. For 2025, its earnings are expected to grow 15.9%. Boston Scientific Corporation price | Boston Scientific Corporation Quote Johnson & Johnson is a healthcare conglomerate with a major MedTech division (Johnson & Johnson MedTech) focused on medical devices and diagnostics. The company employs AI for surgical robotics, digital surgery analytics and imaging. It has developed an ecosystem called Ottava, its next-gen robotic surgery platform, and the Caresurgical/VELYS digital surgery systems, which use data and AI for procedure planning. Its Polyphonic Digital Ecosystem connects operating rooms, allowing surgeons to share live video and data with remote peers. AI in this system helps identify significant events in the surgery video feed for discussion. Johnson & Johnson, carrying a Zacks Rank #2 at present, has a historical earnings growth rate of 5.5%, higher than the industry's 2.8%. The company has a net margin of 24.4%, outperforming the industry's 18.6%. For 2025, its sales are expected to grow 2.8%. Johnson & Johnson price | Johnson & Johnson Quote GE HealthCare is a global leader in medical imaging, diagnostics and healthcare. AI is central to the company's digital strategy, which focuses on its precision care framework. In 2023, it topped the FDA list of AI-enabled medical devices with 80 listed 510(k) clearances or authorizations to date in the United States. Recently, the company has launched CleaRecon DL — an AI-driven solution that enhances cone-beam computed tomography image quality. Also, its Invenia Automated Breast Ultrasound Premium, the latest 3D ultrasound, offers advanced AI and innovative features to drive faster, reproducible supplemental screening and streamline exam readings on patients with dense breasts. GE HealthCare, carrying a Zacks Rank #3 (Hold) at present, has a projected 2025 sales growth rate of 3.2%, higher than the industry's flat growth. The company has a favorable current cashflow rate of 9.7% against the industry's -2.6%. GE HealthCare Technologies Inc. price | GE HealthCare Technologies Inc. Quote Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Boston Scientific Corporation (BSX) : Free Stock Analysis Report Johnson & Johnson (JNJ) : Free Stock Analysis Report Intuitive Surgical, Inc. (ISRG) : Free Stock Analysis Report NVIDIA Corporation (NVDA) : Free Stock Analysis Report GE HealthCare Technologies Inc. (GEHC) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research

BMO Raises GE Vernova (GEV) PT, Keeps Outperform Rating
BMO Raises GE Vernova (GEV) PT, Keeps Outperform Rating

Yahoo

time6 hours ago

  • Yahoo

BMO Raises GE Vernova (GEV) PT, Keeps Outperform Rating

GE Vernova (NYSE:GEV) is one of the 13 Best Large Cap Stocks to Buy Right Now. On July 8, BMO Capital kept an 'Outperform' rating on GE Vernova Inc. (NYSE:GEV) while increasing its price target from $522 to $590. The firm's updated analysis focused on the company's Gas Power business. BMO Capital analysts highlighted strong, contracted earnings growth beyond 2030. This growth is expected to be driven by long-term service agreements (LTSAs) in the gas power service segment. A long convoy of trucks driving across miles of desert, carrying offshore energy services equipment. BMO Capital expects that by 2035, GE Vernova Inc. (NYSE:GEV) will generate about 2.5 times the annual revenue from LTSAs compared to 2024 levels, with gross margins nearly 1000 basis points higher. Additionally, BMO Capital noted that GE Vernova Inc. (NYSE:GEV) has surged 85% over the last three months and near-term valuation metrics may appear stretched at 28 times the firm's estimated 2026 EBITDA. The firm pointed out that while investors recognize the current gas turbine equipment orders can boost earnings from 2028 onward, the market has not fully recognized the significant upside potential from gas power service LTSAs. GE Vernova Inc. (NYSE:GEV) is an energy equipment manufacturing and services company. While we acknowledge the potential of GEV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best American Semiconductor Stocks to Buy Now and 11 Best Fintech Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.

Benchmark Sees Over 200% Upside for Amplify Energy Corp. (AMPY)
Benchmark Sees Over 200% Upside for Amplify Energy Corp. (AMPY)

Yahoo

time7 hours ago

  • Yahoo

Benchmark Sees Over 200% Upside for Amplify Energy Corp. (AMPY)

Amplify Energy Corp. (NYSE:AMPY) is among the . Benchmark has reaffirmed its Buy rating on Amplify Energy Corp. (NYSE:AMPY), with an unchanged price target of $11.00, citing the optimism surrounding the sale of Eagle Ford non-operated production. This potential surge of over 200% from the current levels means that this company is in the right direction to meet its strategic objectives. The research firm highlights that moves like these alleviate investor worries concerning potential acquisitions, leverage problems, and dilution of the company's Beta field prospects. This strategic initiative has the potential to improve the production and capital expenditure guidance for Amplify Energy Corp. (NYSE:AMPY) in August. An oil rig in the midst of extracting oil and natural gas from the earth, illuminated by the setting sun. The results of the company's next Beta well are expected within this quarter, which could advance the current data on the offshore California development that the analysts believe will shape the future for Amplify Energy Corp. (NYSE:AMPY). Amplify Energy Corp. (NYSE:AMPY) is a Texas-based company that, along with its subsidiaries, acquires, exploits, and develops oil and natural gas properties. With a commitment to optimizing production and generating free, sustainable cash flow, the company has properties in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana, and Eagle Ford. While we acknowledge the potential of AMPY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store